ReviewCMI communications2026
Human Q fever outbreak investigation and management in six European countries: a One Health compendium of practices and recommendations.
Review in CMI communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Q fever is a zoonotic disease caused by Objectives: This report aimed to review and compare human Q fever outbreak management protocols across several European countries, identify areas of convergence, highlight operational challenges, and outline key gaps in diagnostic tools, source investigations, and cross-sector coordination. It also seeks to propose research priorities and recommendations to support more coordinated One Health preparedness and response. Sources: The analysis was conducted within the European Union-funded Q‑Net‑Assess project, involving partners from Belgium, France, Germany, Spain, The Netherlands, and the United Kingdom. Information was drawn from national procedures, guideline documents, and operational experiences shared by researchers and experts affiliated with academic, public health, veterinary, and reference laboratories. Content: This report describes practices related to outbreak detection, notification, case investigation, identification of sources, and implementation of control measures across countries. It maps key differences in national protocols, highlighting variability in diagnostic approaches, environmental sampling, molecular typing, and cross-sector coordination. The synthesis identifies both shared methodological elements and structural limitations that affect timely and effective outbreak management. Implications: Findings underscore the need for more harmonized and integrated Q fever outbreak management across Europe. The report outlines research priorities and provides recommendations aimed at strengthening diagnostic capacity, enhancing environmental and molecular investigation tools, and improving One Health collaboration. These insights have potential relevance for other airborne zoonotic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.